Registration - Organization

Janssen Inc. / Laetitia Decroix Guilloux, President

Registration Information

Organization name: Janssen Inc.
Previous Organization names
Senior Officer Name: Laetitia Decroix Guilloux, President
Senior Officer Change History
Initial registration start date: 2010-04-29
Registration status: Active
Projected end date: No date provided
Registration number: 11716-1841

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 10

Lobbying Activity Reports - last 6 months: 1

Version 34 of 36 (2025-07-01 to 2025-10-01)

Registration versions:

Version 34 of 36 (2025-07-01 to 2025-10-01)

Lobbying Information

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
British Columbia's Expensive Drugs for Rare Diseases (EDRD) program. Specifically the proposed delivery of a universal pharmacare program.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
British Columbia's Innovation Agenda: ensuring that the life sciences industry is included and promoting awareness of and support for the full ecosystem from early stage research to commercialization and reimbursement.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health
Development of a joint industry-Government of British Columbia Life Sciences Sector Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health
Ministry of Health's Pharmaceutical Care Services Management Strategy	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
National Pharmacare. Specifically the proposed delivery of a universal pharmacare program.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Reimbursement of patented medicines	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Special Authority Transformation (SAT project)	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Subsequent Entry Biologics & policies related to their reimbursement.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Support British Columbia’s policy and regulatory framework to create a favourable business environment for the development of the life science sector.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade, Health, Science and Technology

BC Ministries/Provincial Entities

Health
Jobs, Economic Development and Innovation
Member(s) of the BC Legislative Assembly
Provincial Health Services Authority

Organization Details

Senior Officer Name and Position during the Period of this Registration

Berkeley Vincent, President

Organization Contact Information

Janssen Inc.

Address:
19 Green Belt Drive
Toronto, ON M3C 1L9
Canada

Description of Activities

Janssen Inc. is a subsidiary of US based Johnson & Johnson and is a bio pharmaceutical company focused on the sales, marketing and distribution of innovative medicines.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

No government funding was received within the preceding 12 months based on the submission date requirements for this registration.

Other Entities (working together for the purposes of lobbying) Information

Janssen Inc. is not working together with any other entity for the purpose of lobbying.

Affiliates with a Direct Interest in the Outcome

Johnson & Johnson
- One Johnson & Johnson Plaza
  New Brunswick, NJ 08933
  United States of America
Johnson & Johnson (Canada) Inc.
- 200 Whitehall Drive
  Markham, ON L3R 0T5
  Canada

Other Persons or Organizations with Direct Interests

The activities of Janssen Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Details

Lobbyists Employed by this Organization

Lobbyist

Contributions

Celesta Basler
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: No

Jennifer Bessant
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No

Lobbied or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this organization, on or after 2024-09-21: No

Monica Da Re
Subscribes to a Code of Conduct: Yes
Former Public Office Holder in BC: No